Sninsky, C A <br/><br/>
Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study.  [electronic resource] 

 -  Annals of internal medicine  Sep 1991 
 - 350-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-4819 
<br/><br/><label>Standard No.: </label>10.7326/0003-4819-115-5-350  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aminosalicylic Acids--adverse effects<br/>Chi-Square Distribution<br/>Colitis, Ulcerative--drug therapy<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Mesalamine<br/>Middle Aged<br/>Severity of Illness Index<br/>Statistics as Topic<br/>Tablets, Enteric-Coated